Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of
SAN DIEGO -- June 24, 2013
Shareholder rights law firm Johnson & Weaver, LLP has commenced an
investigation into whether certain officers and directors of Solazyme, Inc.
(Nasdaq:SZYM) violated state or federal laws when communicating to
shareholders about the Solazyme Roquette Nutritionals joint venture.
According to Johnson & Weaver, LLP, shares of Solazyme have declined more than
10% in early morning trading since the announcement made on June 24, 2013 that
it has agreed with Roquette Frères, S.A. to dissolve their joint venture,
Solazyme Roquette Nutritionals, LLC.
Johnson & Weaver’s investigation is ongoing and addresses the timeline of
possible misleading statements specifically regarding the outlook of the joint
venture with Roquette Frères. Jim Baker, Lead Analyst for Johnson & Weaver,
stated that, “It appears that the project has been in jeopardy for some time
despite statements made by senior management to the contrary.” Baker
continued, “Additionally, management has been aggressively selling their
shares in recent months.”
If you have information that could assist in this investigation, or if you are
a Solazyme shareholder and are interested in learning more about the
investigation or your legal rights and remedies, please contact Jim Baker
(firstname.lastname@example.org)by email or by phone at 619-230-0063 Ext. 118.
Johnson & Weaver, LLP is a nationally recognized shareholders’ rights law
firm. The firm represents individual and institutional investors in
shareholder derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please
Johnson & Weaver, LLP
Jim Baker, Ext. 118
Press spacebar to pause and continue. Press esc to stop.